COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes

COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes

Adenoviral-based vaccines such as ChadoX1 CoV-19 (AstraZeneca) and Ad26.COV2.S (J&J) were developed to prevent infection and reduce hospitalization or death in Coronavirus Disease 2019 (COVID-19) patients. Although these vaccines passed safety and efficacy trials with excellent neutralizing capa...

Full description

Bibliographic Details
Main Authors: Gewil Daniella Olipas Allas, Joekeem Del Rosario Arizala, Rafael Vincent Mercado Manalo
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Hematology Reports
Subjects:
thrombocytopenia
VITT
HIT
TTP
COVID-19
Online Access:https://www.mdpi.com/2038-8330/14/4/50

Similar Items

Similar Items